Wakinyan Benhamou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Wakinyan Benhamou has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Rémi Choquet
CEFE, Univ Montpellier, CNRS, EPHE, IRD – Montpellier, France
6 shared publications - Sylvain Gandon
CEFE, CNRS, Univ Montpellier, EPHE, IRD, Montpellier, France
6 shared publications Bryan T. Grenfell
Princeton University
5 shared publicationsC. Jessica E. Metcalf
Princeton University
5 shared publicationsCécile Viboud
National Institutes of Health
5 shared publicationsEmily Howerton
Princeton University
5 shared publications
Latest Publications
- Open Access
- 11 September 2026
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 22 (9) , e1014784
Leveraging perturbations to infer the population dynamics of human rhinovirus and interaction of influenza A virus
Many respiratory pathogens co-circulate within human populations. Yet, how pathogen community structure shapes the dynamics of infectious diseases remains poorly understood. At the population level, investigating polymicrobial dynamics, with potential underlying competitive or cooperative interactions, is challenging, because of confounding factors such as differing seasonality. This is particularly true for endemic pathogens which typically exhibit stable periodic dynamics. Their disruption due to the implementation of non-pharmaceutical interventions during the COVID-19 pandemic thus represents a unique large-scale natural experiment that can be leveraged to provide valuable insights into the complex interplay between respiratory pathogens. Here, we focus on the population dynamics of human rhinovirus (common cold) and on the potential viral interference of influenza A virus (flu A), which is hypothesized to account for their asynchronous circulation. Using a Bayesian framework, we first show based on simulations that exogenous perturbations can be a powerful tool to disentangle the contribution of pathogen interaction from other epidemiological factors. We then apply our framework to surveillance time series from the US and Canada spanning the COVID-19 pandemic. We estimate key parameters of rhinovirus but find no conclusive support for an influence of influenza A virus at the population level.
- 11 September 2026
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 22 (9) , e1014784
Open AccessLeveraging perturbations to infer the population dynamics of human rhinovirus and interaction of influenza A virus
Many respiratory pathogens co-circulate within human populations. Yet, how pathogen community structure shapes the dynamics of infectious diseases remains poorly understood. At the population level, investigating polymicrobial dynamics, with potential underlying competitive or cooperative interactions, is challenging, because of confounding factors such as differing seasonality. This is particularly true for endemic pathogens which typically exhibit stable periodic dynamics. Their disruption due to the implementation of non-pharmaceutical interventions during the COVID-19 pandemic thus represents a unique large-scale natural experiment that can be leveraged to provide valuable insights into the complex interplay between respiratory pathogens. Here, we focus on the population dynamics of human rhinovirus (common cold) and on the potential viral interference of influenza A virus (flu A), which is hypothesized to account for their asynchronous circulation. Using a Bayesian framework, we first show based on simulations that exogenous perturbations can be a powerful tool to disentangle the contribution of pathogen interaction from other epidemiological factors. We then apply our framework to surveillance time series from the US and Canada spanning the COVID-19 pandemic. We estimate key parameters of rhinovirus but find no conclusive support for an influence of influenza A virus at the population level.
- Open Access
- 15 April 2026
- Published by The Royal Society in Journal of The Royal Society Interface
- Vol. 23 (237)
The interplay between migration and selection on the dynamics of pathogen variants
The fitness advantage of an emerging pathogen variant is typically estimated from its change in frequency over time. This approach relies on the assumption that the pathogen spreads in a well-mixed population, where frequency changes are solely driven by selection. Yet, spatial structure can have major consequences on the spread of new variants. Here, we model the change in frequency across time and across space of a new pathogen variant spreading in a two-patch host metapopulation. Crucially, we show that even small rates of migration can interfere with selection and may bias the estimation of fitness. We illustrate this effect with the evolution of SARS-CoV-2 by contrasting the spread of the Alpha and the Delta variants in England. We contend that the observed heterogeneity of fitness estimates across space could result from the influence of pathogen migration. This work highlights the need for a comprehensive theoretical framework accounting for the interplay between selection and migration on the spread of new pathogen variants.
- 15 April 2026
- Published by The Royal Society in Journal of The Royal Society Interface
- Vol. 23 (237)
Open AccessThe interplay between migration and selection on the dynamics of pathogen variants
The fitness advantage of an emerging pathogen variant is typically estimated from its change in frequency over time. This approach relies on the assumption that the pathogen spreads in a well-mixed population, where frequency changes are solely driven by selection. Yet, spatial structure can have major consequences on the spread of new variants. Here, we model the change in frequency across time and across space of a new pathogen variant spreading in a two-patch host metapopulation. Crucially, we show that even small rates of migration can interfere with selection and may bias the estimation of fitness. We illustrate this effect with the evolution of SARS-CoV-2 by contrasting the spread of the Alpha and the Delta variants in England. We contend that the observed heterogeneity of fitness estimates across space could result from the influence of pathogen migration. This work highlights the need for a comprehensive theoretical framework accounting for the interplay between selection and migration on the spread of new pathogen variants.
- Open Access
Leveraging perturbations to infer the population dynamics of human rhinovirus and interaction of influenza A virus
Many respiratory pathogens co-circulate within human populations. Yet, how pathogen community structure shapes the dynamics of infectious diseases remains poorly understood. At the population level, investigating polymicrobial dynamics, with potential underlying competitive or cooperative interactions, is challenging, because of confounding factors such as differing seasonality. This is particularly true for endemic pathogens which typically exhibit stable periodic dynamics. Their disruption due to the implementation of non-pharmaceutical interventions during the COVID-19 pandemic thus represents a unique large-scale natural experiment that can be leveraged to provide valuable insights into the complex interplay between respiratory pathogens. Here, we focus on the population dynamics of human rhinovirus (common cold) and on the potential viral interference of influenza A virus (flu A), which is hypothesized to account for their asynchronous circulation. Using a Bayesian framework, we first show based on simulations that exogenous perturbations can be a powerful tool to disentangle the contribution of pathogen interaction from other epidemiological factors. We then apply our framework to long surveillance time series from the US and Canada spanning the COVID-19 pandemic. We estimate key parameters of rhinovirus but find no conclusive support for an influence of influenza A virus at the population level.
Open AccessLeveraging perturbations to infer the population dynamics of human rhinovirus and interaction of influenza A virus
Many respiratory pathogens co-circulate within human populations. Yet, how pathogen community structure shapes the dynamics of infectious diseases remains poorly understood. At the population level, investigating polymicrobial dynamics, with potential underlying competitive or cooperative interactions, is challenging, because of confounding factors such as differing seasonality. This is particularly true for endemic pathogens which typically exhibit stable periodic dynamics. Their disruption due to the implementation of non-pharmaceutical interventions during the COVID-19 pandemic thus represents a unique large-scale natural experiment that can be leveraged to provide valuable insights into the complex interplay between respiratory pathogens. Here, we focus on the population dynamics of human rhinovirus (common cold) and on the potential viral interference of influenza A virus (flu A), which is hypothesized to account for their asynchronous circulation. Using a Bayesian framework, we first show based on simulations that exogenous perturbations can be a powerful tool to disentangle the contribution of pathogen interaction from other epidemiological factors. We then apply our framework to long surveillance time series from the US and Canada spanning the COVID-19 pandemic. We estimate key parameters of rhinovirus but find no conclusive support for an influence of influenza A virus at the population level.
- Open Access
The interplay between migration and selection on the dynamics of pathogen variants
The fitness advantage of an emerging pathogen variant is typically estimated from its change in frequency over time. This approach relies on the assumption that the pathogen spreads in a well-mixed population, where frequency changes are solely driven by selection. Yet, spatial structure can have major consequences on the spread of new variants. Here we model the change in frequency across time and across space of a new pathogen variant spreading in a two-patch host metapopulation. Crucially, we show that even small rates of migration can interfere with selection and may bias the estimation of fitness. We illustrate this effect with the evolution of SARS-CoV-2 by contrasting the spread of the Alpha and the Delta variants in England. We contend that the observed heterogeneity of fitness estimates across space could result from the influence of pathogen migration. This work highlights the need of a comprehensive theoretical framework accounting for the interplay between selection and migration on the spread of new pathogen variants.
Open AccessThe interplay between migration and selection on the dynamics of pathogen variants
The fitness advantage of an emerging pathogen variant is typically estimated from its change in frequency over time. This approach relies on the assumption that the pathogen spreads in a well-mixed population, where frequency changes are solely driven by selection. Yet, spatial structure can have major consequences on the spread of new variants. Here we model the change in frequency across time and across space of a new pathogen variant spreading in a two-patch host metapopulation. Crucially, we show that even small rates of migration can interfere with selection and may bias the estimation of fitness. We illustrate this effect with the evolution of SARS-CoV-2 by contrasting the spread of the Alpha and the Delta variants in England. We contend that the observed heterogeneity of fitness estimates across space could result from the influence of pathogen migration. This work highlights the need of a comprehensive theoretical framework accounting for the interplay between selection and migration on the spread of new pathogen variants.
- Open Access
- 15 October 2024
- Published by Oxford University Press (OUP) in Virus Evolution
- Vol. 10 (1) , veae069
Evolution of virulence in emerging epidemics: from theory to experimental evolution and back
The experimental validation of theoretical predictions is a crucial step in demonstrating the predictive power of a model. While quantitative validations are common in infectious diseases epidemiology, experimental microbiology primarily focuses on the evaluation of a qualitative match between model predictions and experiments. In this study, we develop a method to deepen the quantitative validation process with a polymorphic viral population. We analyse the data from an experiment carried out to monitor the evolution of the temperate bacteriophage λ spreading in continuous cultures of Escherichia coli. This experimental work confirmed the influence of the epidemiological dynamics on the evolution of transmission and virulence of the virus. A variant with larger propensity to lyse bacterial cells was favoured in emerging epidemics (when the density of susceptible cells was large), but counter-selected when most cells were infected. Although this approach qualitatively validated an important theoretical prediction, no attempt was made to fit the model to the data nor to further develop the model to improve the goodness of fit. Here, we show how theoretical analysis – including calculations of the selection gradients – and model fitting can be used to estimate key parameters of the phage life cycle and yield new insights on the evolutionary epidemiology of the phage λ. First, we show that modelling explicitly the infected bacterial cells which will eventually be lysed improves the fit of the transient dynamics of the model to the data. Second, we carry out a theoretical analysis that yields useful approximations that capture at the onset and at the end of an epidemic the effects of epidemiological dynamics on selection and differentiation across distinct life stages of the virus. Finally, we estimate key phenotypic traits characterizing the two strains of the virus used in our experiment such as the rates of prophage reactivation or the probabilities of lysogenization. This study illustrates the synergy between experimental, theoretical and statistical approaches; and especially how interpreting the temporal variation in the selection gradient and the differentiation across distinct life stages of a novel variant is a powerful tool to elucidate the evolutionary epidemiology of emerging infectious diseases.
- 15 October 2024
- Published by Oxford University Press (OUP) in Virus Evolution
- Vol. 10 (1) , veae069
Open AccessEvolution of virulence in emerging epidemics: from theory to experimental evolution and back
The experimental validation of theoretical predictions is a crucial step in demonstrating the predictive power of a model. While quantitative validations are common in infectious diseases epidemiology, experimental microbiology primarily focuses on the evaluation of a qualitative match between model predictions and experiments. In this study, we develop a method to deepen the quantitative validation process with a polymorphic viral population. We analyse the data from an experiment carried out to monitor the evolution of the temperate bacteriophage λ spreading in continuous cultures of Escherichia coli. This experimental work confirmed the influence of the epidemiological dynamics on the evolution of transmission and virulence of the virus. A variant with larger propensity to lyse bacterial cells was favoured in emerging epidemics (when the density of susceptible cells was large), but counter-selected when most cells were infected. Although this approach qualitatively validated an important theoretical prediction, no attempt was made to fit the model to the data nor to further develop the model to improve the goodness of fit. Here, we show how theoretical analysis – including calculations of the selection gradients – and model fitting can be used to estimate key parameters of the phage life cycle and yield new insights on the evolutionary epidemiology of the phage λ. First, we show that modelling explicitly the infected bacterial cells which will eventually be lysed improves the fit of the transient dynamics of the model to the data. Second, we carry out a theoretical analysis that yields useful approximations that capture at the onset and at the end of an epidemic the effects of epidemiological dynamics on selection and differentiation across distinct life stages of the virus. Finally, we estimate key phenotypic traits characterizing the two strains of the virus used in our experiment such as the rates of prophage reactivation or the probabilities of lysogenization. This study illustrates the synergy between experimental, theoretical and statistical approaches; and especially how interpreting the temporal variation in the selection gradient and the differentiation across distinct life stages of a novel variant is a powerful tool to elucidate the evolutionary epidemiology of emerging infectious diseases.
- Open Access
Evolution of Virulence in Emerging Epidemics: From Theory to Experimental Evolution and Back
The experimental validation of theoretical predictions is a crucial step in demonstrating the predictive power of a model. While quantitative validations are common in infectious diseases epidemiology, experimental microbiology primarily focuses on the evaluation of a qualitative match between model predictions and experiments. In this study, we develop a method to deepen the quantitative validation process with a polymorphic viral population. We analyse the data from an experiment carried out to monitor the evolution of the temperate bacteriophage λ spreading in continuous cultures of Escherichia coli . This experimental work confirmed the influence of the epidemiological dynamics on the evolution of transmission and virulence of the virus. A variant with larger propensity to lyse bacterial cells was favoured in emerging epidemics (when the density of susceptible cells was large), but counter-selected when most cells were infected. Although this approach qualitatively validated an important theoretical prediction, no attempt was made to fit the model to the data nor to further develop the model to improve the goodness of fit. Here, we show how theoretical analysis – including calculations of the selection gradients – and model fitting can be used to estimate key parameters of the phage life cycle and yield new insights on the evolutionary epidemiology of the phage λ. First, we show that modelling explicitly the infected bacterial cells which will eventually be lysed improves the fit of the transient dynamics of the model to the data. Second, we carry out a theoretical analysis that yields useful approximations that capture at the onset and at the end of an epidemic the effects of epidemiological dynamics on selection and differentiation across distinct life stages of the virus. Finally, we estimate key phenotypic traits characterizing the two strains of the virus used in our experiment such as the rates of prophage reactivation or the probabilities of lysogenization. This study illustrates the synergy between experimental, theoretical and statistical approaches; and especially how interpreting the temporal variation in the selection gradient and the differentiation across distinct life stages of a novel variant is a powerful tool to elucidate the evolutionary epidemiology of emerging infectious diseases.
Open AccessEvolution of Virulence in Emerging Epidemics: From Theory to Experimental Evolution and Back
The experimental validation of theoretical predictions is a crucial step in demonstrating the predictive power of a model. While quantitative validations are common in infectious diseases epidemiology, experimental microbiology primarily focuses on the evaluation of a qualitative match between model predictions and experiments. In this study, we develop a method to deepen the quantitative validation process with a polymorphic viral population. We analyse the data from an experiment carried out to monitor the evolution of the temperate bacteriophage λ spreading in continuous cultures of Escherichia coli . This experimental work confirmed the influence of the epidemiological dynamics on the evolution of transmission and virulence of the virus. A variant with larger propensity to lyse bacterial cells was favoured in emerging epidemics (when the density of susceptible cells was large), but counter-selected when most cells were infected. Although this approach qualitatively validated an important theoretical prediction, no attempt was made to fit the model to the data nor to further develop the model to improve the goodness of fit. Here, we show how theoretical analysis – including calculations of the selection gradients – and model fitting can be used to estimate key parameters of the phage life cycle and yield new insights on the evolutionary epidemiology of the phage λ. First, we show that modelling explicitly the infected bacterial cells which will eventually be lysed improves the fit of the transient dynamics of the model to the data. Second, we carry out a theoretical analysis that yields useful approximations that capture at the onset and at the end of an epidemic the effects of epidemiological dynamics on selection and differentiation across distinct life stages of the virus. Finally, we estimate key phenotypic traits characterizing the two strains of the virus used in our experiment such as the rates of prophage reactivation or the probabilities of lysogenization. This study illustrates the synergy between experimental, theoretical and statistical approaches; and especially how interpreting the temporal variation in the selection gradient and the differentiation across distinct life stages of a novel variant is a powerful tool to elucidate the evolutionary epidemiology of emerging infectious diseases.
- 19 July 2023
- Published by Oxford University Press (OUP) in Evolution
- Vol. 77 (10) , 2213-2223
Phenotypic evolution of SARS-CoV-2: a statistical inference approach
Since its emergence in late 2019, the SARS-CoV-2 virus has spread globally, causing the ongoing COVID-19 pandemic. In the fall of 2020, the Alpha variant (lineage B.1.1.7) was detected in England and spread rapidly, outcompeting the previous lineage. Yet, very little is known about the underlying modifications of the infection process that can explain this selective advantage. Here, we try to quantify how the Alpha variant differed from its predecessor on two phenotypic traits: the transmission rate and the duration of infectiousness. To this end, we analysed the joint epidemiological and evolutionary dynamics as a function of the Stringency Index, a measure of the amount of Non-Pharmaceutical Interventions. Assuming that these control measures reduce contact rates and transmission, we developed a two-step approach based on SEIR models and the analysis of a combination of epidemiological and evolutionary information. First, we quantify the link between the Stringency Index and the reduction in viral transmission. Secondly, based on a novel theoretical derivation of the selection gradient in an SEIR model, we infer the phenotype of the Alpha variant from its frequency changes. We show that its selective advantage is more likely to result from a higher transmission than from a longer infectious period. Our work illustrates how the analysis of the joint epidemiological and evolutionary dynamics of infectious diseases can help understand the phenotypic evolution driving pathogen adaptation.
- 19 July 2023
- Published by Oxford University Press (OUP) in Evolution
- Vol. 77 (10) , 2213-2223
Phenotypic evolution of SARS-CoV-2: a statistical inference approach
Since its emergence in late 2019, the SARS-CoV-2 virus has spread globally, causing the ongoing COVID-19 pandemic. In the fall of 2020, the Alpha variant (lineage B.1.1.7) was detected in England and spread rapidly, outcompeting the previous lineage. Yet, very little is known about the underlying modifications of the infection process that can explain this selective advantage. Here, we try to quantify how the Alpha variant differed from its predecessor on two phenotypic traits: the transmission rate and the duration of infectiousness. To this end, we analysed the joint epidemiological and evolutionary dynamics as a function of the Stringency Index, a measure of the amount of Non-Pharmaceutical Interventions. Assuming that these control measures reduce contact rates and transmission, we developed a two-step approach based on SEIR models and the analysis of a combination of epidemiological and evolutionary information. First, we quantify the link between the Stringency Index and the reduction in viral transmission. Secondly, based on a novel theoretical derivation of the selection gradient in an SEIR model, we infer the phenotype of the Alpha variant from its frequency changes. We show that its selective advantage is more likely to result from a higher transmission than from a longer infectious period. Our work illustrates how the analysis of the joint epidemiological and evolutionary dynamics of infectious diseases can help understand the phenotypic evolution driving pathogen adaptation.
- Open Access
Phenotypic evolution of SARS-CoV-2: a statistical inference approach
Since its emergence in late 2019, the SARS-CoV-2 virus has spread globally, causing the ongoing COVID-19 pandemic. In the fall of 2020, the Alpha variant (lineage B.1.1.7) was detected in England and spread rapidly, outcompeting the previous lineage. Yet, very little is known about the underlying modifications of the infection process that can explain this selective advantage. Here, we try to quantify how the Alpha variant differed from its predecessor on two phenotypic traits: the transmission rate and the duration of infectiousness. To this end, we analysed the joint epidemiological and evolutionary dynamics as a function of the Stringency Index, a measure of the amount of Non-Pharmaceutical Interventions. Assuming that these control measures reduce contact rates and transmission, we developed a two-step approach based on SEIR models and the analysis of a combination of epidemiological and evolutionary information. First, we quantify the link between Stringency Index and the reduction in viral transmission. Secondly, based on a novel theoretical derivation of the selection gradient in an SEIR model, we infer the phenotype of the Alpha variant from its frequency changes. We show that its selective advantage is more likely to result from a higher transmission than from a longer infectious period.
Open AccessPhenotypic evolution of SARS-CoV-2: a statistical inference approach
Since its emergence in late 2019, the SARS-CoV-2 virus has spread globally, causing the ongoing COVID-19 pandemic. In the fall of 2020, the Alpha variant (lineage B.1.1.7) was detected in England and spread rapidly, outcompeting the previous lineage. Yet, very little is known about the underlying modifications of the infection process that can explain this selective advantage. Here, we try to quantify how the Alpha variant differed from its predecessor on two phenotypic traits: the transmission rate and the duration of infectiousness. To this end, we analysed the joint epidemiological and evolutionary dynamics as a function of the Stringency Index, a measure of the amount of Non-Pharmaceutical Interventions. Assuming that these control measures reduce contact rates and transmission, we developed a two-step approach based on SEIR models and the analysis of a combination of epidemiological and evolutionary information. First, we quantify the link between Stringency Index and the reduction in viral transmission. Secondly, based on a novel theoretical derivation of the selection gradient in an SEIR model, we infer the phenotype of the Alpha variant from its frequency changes. We show that its selective advantage is more likely to result from a higher transmission than from a longer infectious period.
- Open Access
- Vol. 22 (9) , e1014784
Leveraging perturbations to infer the population dynamics of human rhinovirus and interaction of influenza A virus
- Vol. 22 (9) , e1014784
Open AccessLeveraging perturbations to infer the population dynamics of human rhinovirus and interaction of influenza A virus
- Open Access
- Vol. 22 (9) , e1014784
Leveraging perturbations to infer the population dynamics of human rhinovirus and interaction of influenza A virus
- Vol. 22 (9) , e1014784
Open AccessLeveraging perturbations to infer the population dynamics of human rhinovirus and interaction of influenza A virus